missing translation for 'onlineSavingsMsg'
Learn More

Tocris Bioscience™ RIPK2 inhibitor 1

Potent RIPK2 inhibitor

1910.00 NOK - 7205.00 NOK

Specifications

Chemical Name or Material 3-(Benzoylamino)-4-methyl-N-[3-(1-methyl-1H-imidazol-2-yl)phenyl]benzamide
CAS 1290490-78-6
Target RIP Kinase Inhibitors
Molecular Formula C25H22N4O2
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18749266
View Documents
Tocris Bioscience™
6603/10
10 mg
1910.00 NOK
10mg
Please to purchase this item. Need a web account? Register with us today!
18707626
View Documents
Tocris Bioscience™
6603/50
50 mg
7205.00 NOK
50mg
Please to purchase this item. Need a web account? Register with us today!
Description

Description

RIPK2 inhibitor 1 is a potent receptor-interacting protein kinase 2 (RIPK2) inhibitor (IC50 of 5-10 nM). It inhibits NF-κB activity and decreases cancer cell proliferation by 70%. In vivo, RIPK2 inhibitor 1 inhibits intestinal and lung inflammation with low toxicity in rodent models.
Specifications

Specifications

3-(Benzoylamino)-4-methyl-N-[3-(1-methyl-1H-imidazol-2-yl)phenyl]benzamide
1290490-78-6
RIP Kinase Inhibitors
C25H22N4O2
Videos
Safety and Handling

Safety and Handling

Recommended Storage : Store the unopened product at -20 to -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.

SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.